Translational Approach to KRAS Inhibitors & Mapping the Possible Mechanism of KRASi Resistance
- The KRAS inhibitor Landscape: From Discovery to Clinical Hurdles
- Establishment of Sotorasib and Adagrasib resistance PDX models. Leveraging MiniPDX and PDX Models for next generation KRASi screening
- Decoding resistance mechanism through integrated bioinformatics